Wolverine Trading
ALT icon

Wolverine Trading’s Altimmune ALT Stock Holding History

Wolverine Trading’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$637K Sell
168,200
-20,000
-11% -$77.2K ﹤0.01% 3418
2025
Q2 		$659K Buy
188,200
+61,400
+48% +$332K ﹤0.01% 2686
2025
Q1 		$675K Buy
126,800
+21,300
+20% +$135K ﹤0.01% 2627
2024
Q4 		$772K Buy
105,500
+30,200
+40% +$231K ﹤0.01% 2927
2024
Q3 		$487K Sell
75,300
-6,000
-7% -$40.6K ﹤0.01% 3077
2024
Q2 		$541K Buy
81,300
+16,300
+25% +$120K ﹤0.01% 2764
2024
Q1 		$662K Sell
65,000
-43,900
-40% -$447K ﹤0.01% 2587
2023
Q4 		$1.23M Buy
108,900
+32,800
+43% +$137K ﹤0.01% 2109
2023
Q3 		$198K Buy
76,100
+28,800
+61% +$82.6K ﹤0.01% 3749
2023
Q2 		$166K Sell
47,300
-39,800
-46% -$179K ﹤0.01% 3599
2023
Q1 		$368K Buy
87,100
+3,300
+4% +$39.2K ﹤0.01% 2804
2022
Q4 		$1.38M Buy
83,800
+3,300
+4% +$37.1K ﹤0.01% 1622
2022
Q3 		$1.02M Buy
80,500
+50,700
+170% +$749K ﹤0.01% 1952
2022
Q2 		$351K Buy
+29,800
New +$184K ﹤0.01% 2897
2022
Q1 		– Sell
-17,300
Closed -$154K – 5334
2021
Q4 		$154K Sell
17,300
-26,000
-60% -$276K ﹤0.01% 4874
2021
Q3 		$553K Buy
43,300
+12,100
+39% +$147K ﹤0.01% 3785
2021
Q2 		$496K Buy
31,200
+300
+1% +$4.1K ﹤0.01% 3693
2021
Q1 		$419K Sell
30,900
-7,300
-19% -$118K ﹤0.01% 3977
2020
Q4 		$432K Buy
38,200
+8,500
+29% +$100K ﹤0.01% 3331
2020
Q3 		$386K Buy
29,700
+12,900
+77% +$258K ﹤0.01% 3093
2020
Q2 		$175K Buy
+16,800
New +$92.3K ﹤0.01% 3903

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's ALT Position: Q3 2025 in Review

Wolverine Trading reduced its Altimmune (ALT) stake by 52% in Q3 2025, selling an estimated $91.5K and leaving 21,820 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5264.

Wolverine Trading first reported a position in ALT in Q4 2020 and has held it in 15 quarters since. The position peaked at $713K in Q4 2023. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Wolverine Trading held 21,820 shares of Altimmune worth $82.7K as of Q3 2025.
  • Wolverine Trading sold 23,708 Altimmune shares in Q3 2025, an estimated $91.5K.
  • Altimmune made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5264 holding.
  • Wolverine Trading first reported a position in Altimmune in Q4 2020 and has held it in 15 quarters since.
  • Wolverine Trading's Altimmune position peaked at $713K in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.